Pediatrics PRN Focus Session — Navigating the Medical Complexities of the Medically Complex Child: An Overview of Autonomic Dysreflexia, Paroxysmal Sympathetic Hyperactivity and Beyond
Saturday, October 12, 2024 from 1:45 PM to 3:15 PM MST
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-133-L01-P
Activity Type: A Knowledge-Based Activity
This session aims to address four objectives and will provide a review of the background for of recent literature related to the treatment and monitoring of autonomic dysreflexia (AD) versus paroxysmal sympathetic hyperactivity (PSH), previously known as dysautonomia, in pediatric patients. The target audience of this session is all pediatric pharmacists in both the inpatient and outpatient settings who care for infants and children that are complex, chronic patients. It is the purpose of this session to provide the pharmacist with the knowledge and tools to appropriately treat these high-risk patients.
Faculty
 | | Moderator: | Michael Raschka, Pharm.D., BCPPS |
|
Learning Objectives
1. Define autonomic dysreflexia (AD) and paroxysmal sympathetic hyperactivity (PSH).
2. Review the various therapies for AD and PSH.
3. Discuss the controversies and considerations surrounding therapies for AD and PSH.
4. Describe the role of pharmacists in the care of children with complex needs.
Management of Autonomic Dysreflexia (AD)1:45 PM to 2:15 PM |
Management of Paroxysmal Sympathetic Hyperactivity (PSH)2:15 PM to 2:45 PM  | | Speaker: | Patrik Miller, Pharm.D., BCPPS |
|
|
Patient Case and Pro-Con Debate (Panel)2:45 PM to 3:15 PM |